10X Genomics
Logotype for 10X Genomics Inc

10X Genomics (TXG) investor relations material

10X Genomics TD Cowen 46th Annual Health Care Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for 10X Genomics Inc
TD Cowen 46th Annual Health Care Conference summary3 Mar, 2026

Business performance and financials

  • Achieved double-digit growth in Chromium and Spatial Consumables, despite a challenging CapEx environment and reliance on U.S. academic and government funding.

  • Ended the year with $100 million more cash, totaling $520 million, reflecting a strong balance sheet and focus on cash flow.

  • Guidance for 2026 projects 0%-4% underlying growth, assuming macro conditions similar to the second half of 2025.

  • CapEx for instrumentation expected to decline in the teens, offset by double-digit growth in Spatial Consumables, especially from the Xenium franchise.

  • Single-cell consumables, about half of the business, expected to be flat at the midpoint of guidance, with price-volume trade-offs from new product launches.

Product innovation and adoption

  • Launched Flex Apex in Q4, reducing pricing and unlocking new customer bases and applications.

  • Flex products, including Flex Apex, saw significant uptake, but not all customers or applications are expected to migrate immediately.

  • Price reductions are driving volume growth, with Q4 2025 showing over 30% volume increase and price declines in the 20% range.

  • Ongoing innovation with GEM-X and Flex products strengthens the product portfolio and customer feedback is positive.

  • Building a CLIA lab to offer services for both spatial and single-cell applications, aiming to make transactions more frictionless for biopharma customers.

Market trends and customer segments

  • U.S. academic and government funding was down more than the overall business, but growth in China and other regions provided bright spots.

  • Biopharma represents 20% of business today, with potential to grow to half; share of wallet in these accounts remains small.

  • Large-scale, AI-driven projects and public-private partnerships are emerging as new growth opportunities.

  • Customer enthusiasm for Xenium remains high, with opportunities to increase utilization within the existing install base.

  • Visium platform continues to have an enthusiastic customer base, though interest is shifting toward Xenium.

NIH funding recovery impact on 10x?
FlexApex's effect on single-cell revenue?
Biopharma growth strategy for single-cell
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next 10X Genomics earnings date

Logotype for 10X Genomics Inc
Q1 20267 May, 2026
10X Genomics
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next 10X Genomics earnings date

Logotype for 10X Genomics Inc
Q1 20267 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

10x Genomics, Inc. is a life science technology company that develops and sells instruments, consumables, and software for analyzing biological systems. The Company's proprietary sequencing technology establishes the framework for interrogating vast amounts of genetic information from thousands of samples at a cost and speed that rivals other sequencing methodology. Its products can obtain billions of sequence reads within a few days to weeks in order to support complex experiments and provide high-quality results that accurately reflect genetic variation across the human genome.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage